INDIVIOR PHARMACEUTICALS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+79.5% +$70M
$158M
Free Cash Flow↓-50.0% -$8M
$-24M
Investing Cash Flow↓-120.0% -$30M
$-5M
Financing Cash Flow↑+69.6% +$39M
$-17M
Capex↑+50.0% +$8M
$24M
Stock Buybacks↓-100.0% -$50M
$0
Stock-Based Comp↓-16.7% -$1M
$5M
Debt Repaid↓-97.9% -$233M
$5M
D&A↓-60.0% -$3M
$2M
SBC Allocated Expense↓-16.7% -$1M
$5M